دورية أكاديمية
Hypomethylating agents (HMAs) show benefit in AML rather than in intermediate/high-risk MDS based on genetic mutations in epigenetic modification (EMMs): from a retrospective study
| العنوان: | Hypomethylating agents (HMAs) show benefit in AML rather than in intermediate/high-risk MDS based on genetic mutations in epigenetic modification (EMMs): from a retrospective study |
|---|---|
| المؤلفون: | Wang, RuiqiAff1, Aff2, Xu, Yuanyuan, Wang, Bianhong, Wang, HongAff1, Aff2, Wang, MengzhenAff1, Aff2, Jing, Yu, Gao, XiaoningAff2, IDs00277023054385_cor7, Yu, LiAff1, Aff2, Aff3, IDs00277023054385_cor8 |
| المصدر: | Annals of Hematology. 103(1):61-71 |
| قاعدة البيانات: | Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 09395555 14320584 |
|---|---|
| DOI: | 10.1007/s00277-023-05438-5 |